Efficacy of Oncoxin-Viusid on the Reduction of Adverse Reactions to Chemotherapy and Radiotherapy in Patients Diagnosed with Cervical Cancer and Endometrial Adenocarcinoma

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"Efficacy of Oncoxin-Viusid on the Reduction of Adverse Reactions to Chemotherapy and Radiotherapy in Patients Diagnosed with Cervical Cancer and Endometrial Adenocarcinoma"
written by Raiza Ruiz Lorente, Daysi Hernández Durán, Jessica García Viamontes, Juan Lence Anta, Rosa Ortiz Reyes, Eduardo Sanz Navares,
published by Journal of Cancer Therapy, Vol.11 No.5, 2020

has been cited by the following article(s):

[1]	The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant …
	Journal of Cancer …, 2022

[2]	СИРОП КОРНЯ СОЛОДКИ С ДОБАВКАМИ БИОЛОГИЧЕСКИ АКТИВНЫХ ВЕЩЕСТВ И СПОСОБ ПОЛУЧЕНИЯ СИРОПА НА ЭЛЕКТРОХИМИЧЕСКИ …
	… технологий в медицине и …, 2021

[3]	Ocoxin oral solution demonstrates antiviral properties in cellular models
	2021

[4]	Ocoxin as a complement to first line treatments in cancer
	2021

[5]	Oncoxin‑Viusid® may improve quality of life and survival in patients with hormone‑refractory prostate cancer undergoing onco‑specific treatments
	2020

[6]	Antitumoral Properties of the Nutritional Supplement Ocoxin Oral Solution: A Comprehensive Review
	2020

[7]	Биологически активные добавки. Разработка и маркетинг
	Известия ГГТУ …, 2020

[8]	Ocoxin osagarri naturalaren eragin antitumorala pankreako minbiziko eta kolon-ondesteko minbiziaren metastasi hepatikoko eredu esperimentaletan.
	2020

[1]	Improving the Antitumor Effect of Chemotherapy with Ocoxin as a Novel Adjuvant Agent to Treat Prostate Cancer Nutrients, 2023 DOI:10.3390/nu15112536

[2]	Ocoxin oral solution demonstrates antiviral properties in cellular models Experimental and Therapeutic Medicine, 2021 DOI:10.3892/etm.2021.10561

[3]	Oncoxin‑Viusid^® may improve quality of life and survival in patients with hormone‑refractory prostate cancer undergoing onco‑specific treatments Molecular and Clinical Oncology, 2020 DOI:10.3892/mco.2020.2167

[4]	Antitumoral Properties of the Nutritional Supplement Ocoxin Oral Solution: A Comprehensive Review Nutrients, 2020 DOI:10.3390/nu12092661

Follow SCIRP